Cargando…

The Proper Ki-67 Cut-Off in Hormone Responsive Breast Cancer: A Monoinstitutional Analysis with Long-Term Follow-Up

INTRODUCTION: Breast cancer is a heterogeneous disease. Our study focuses on a monoinstitutional series of patients affected by Hormone Responsive carcinomas (luminal A and luminal B) and aims to define an optimal Ki-67 cut-off, to correctly stratify these patients into risk classes, using the Immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lombardi, Augusto, Lazzeroni, Rachele, Bersigotti, Laura, Vitale, Valeria, Amanti, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039013/ https://www.ncbi.nlm.nih.gov/pubmed/33854368 http://dx.doi.org/10.2147/BCTT.S305440

Ejemplares similares

Positive margins (R1) risk factors in breast cancer conservative surgery
por: Lombardi, Augusto, et al.
Publicado: (2019)

MON-417 Is There a Cut-Off of Ki-67 Indicative of Pituitary Carcinoma?
por: Ferreira, Maria João, et al.
Publicado: (2019)

Prognostic Value of Ki67 in Patients with Stage 1–2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor
por: Jiang, Peng, et al.
Publicado: (2020)

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value
por: Ciruelos, E, et al.
Publicado: (2011)

Importance of perforating vessels in nipple-sparing mastectomy: an anatomical description
por: Amanti, Claudio, et al.
Publicado: (2015)

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up
por: Bustreo, Sara, et al.
Publicado: (2016)

The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014)

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
por: Tashima, Rumiko, et al.
Publicado: (2015)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Ki67 testing in the clinical management of patients with non-metastatic colorectal cancer: Detecting the optimal cut-off value based on the Restricted Cubic Spline model
por: Lei, Hong Tao, et al.
Publicado: (2022)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
por: Borzillo, Valentina, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Proper Cut-off Levels of Serum Specific IgE to Cefaclor for Patients with Cefaclor Allergy
por: Nam, Young-Hee, et al.
Publicado: (2018)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience
por: Di Carlo, Clelia, et al.
Publicado: (2021)

PO-1456 Impact of COVID-19 pandemic to radiotherapy activities: a monoinstitutional evaluation
por: Patani, F., et al.
Publicado: (2021)

Caveolin-1, GATA-3, and Ki67 expressions and their correlation with pathological findings in canine bladder urothelial carcinoma
por: Govoni, Verônica Mollica, et al.
Publicado: (2022)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
por: Lazzeroni, M, et al.
Publicado: (2013)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
por: Mesko, Shane, et al.
Publicado: (2013)

Ki-67 Expression in Hydatidiform Moles and Hydropic Abortions
por: Khooei, Alireza, et al.
Publicado: (2013)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8s47e5lk3557ll00d53b0qq2i3